Bank Pictet & Cie (Europe)’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-12,470
Closed -$2.65M 174
2014
Q4
$2.65M Sell
12,470
-2,100
-14% -$418K 0.68% 38
2014
Q3
$2.6M Sell
14,570
-251
-2% -$41.7K 0.7% 37
2014
Q2
$2.51M Sell
14,821
-85,580
-85% -$13.3M 0.77% 38
2014
Q1
$12.5M Buy
100,401
+8,015
+9% +$976K 4.33% 4
2013
Q4
$10.3M Buy
+92,386
New +$8.82M 4.03% 6

Other funds holding AGN

Bank Pictet & Cie (Europe)'s AGN Position: Q1 2015 in Review

Bank Pictet & Cie (Europe) sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 12,470 shares — an estimated $2.65M sold.

Bank Pictet & Cie (Europe) first reported a position in AGN in Q4 2013 and held it in 5 quarters. The position peaked at $12.5M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Bank Pictet & Cie (Europe) reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 12,470 Allergan Inc shares in Q1 2015, an estimated $2.65M.
  • Bank Pictet & Cie (Europe) first reported a position in Allergan Inc in Q4 2013 and held it in 5 quarters.
  • Bank Pictet & Cie (Europe)'s Allergan Inc position peaked at $12.5M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2015, filed 8 May 2015.